Tuesday, April 7, 2020
Patients of Metastatic Prostate Cancer Could Benefit from Immunotherapy Treatment | Cancer Network
Patients of Metastatic Prostate Cancer Could Benefit from Immunotherapy Treatment | Cancer Network: A recent study found that a group of patients with metastatic castration-resistant prostate cancer responded positively to treatment with ipilimumab, prolonging survival after treatment in the “favorable” cohort.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment